# HA-WBRT-SIB for Brain Metastasis of Lung Cancer

> **NCT06289023** · PHASE2 · COMPLETED · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 40 (actual)

## Conditions studied

- Lung Neoplasm
- Brain Metastases
- Simultaneous Integrated Boost
- Hippocampal Avoidance
- Cognitive Function

## Interventions

- **RADIATION:** HA-WBRT-SIB

## Key facts

- **NCT ID:** NCT06289023
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06289023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06289023, "HA-WBRT-SIB for Brain Metastasis of Lung Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06289023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*